Nautilus Biotechnolgy, Inc.(NAUT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NAUT Nautilus Biotechnolgy, Inc.

盘后交易 04-27 16:33:06 EDT

2.57

-0.05

-1.91%

盘后2.57

+0.000.00%

16:10 EDT

最高2.84	最低2.57	成交量31.79万
今开2.63	昨收2.62	日振幅10.31%
总市值3.25亿	流通市值1.19亿	总股本1.26亿
成交额85.59万	换手率0.69%	流通股本4,628万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NAUT","market":"US","secType":"STK","nameCN":"Nautilus Biotechnolgy, Inc.","latestPrice":2.57,"timestamp":1777320000000,"preClose":2.62,"halted":0,"volume":317943,"hourTrading":{"tag":"盘后","latestPrice":2.57,"preClose":2.57,"latestTime":"16:10 EDT","volume":15,"amount":38.55,"timestamp":1777320604874,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.019083969465648956,"floatShares":46279068,"shares":126305122,"eps":-0.46731,"marketStatus":"盘后交易","change":-0.05,"latestTime":"04-27 16:33:06 EDT","open":2.63,"high":2.84,"low":2.57,"amount":855878.439369,"amplitude":0.103053,"askPrice":2.83,"askSize":100,"bidPrice":2.56,"bidSize":2500,"shortable":3,"etf":0,"ttmEps":-0.46731,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1777334400000},"marketStatusCode":4,"adr":0,"listingDate":1596772800000,"exchange":"NASDAQ","adjPreClose":2.62,"preHourTrading":{"tag":"盘前","latestPrice":2.66,"preClose":2.62,"latestTime":"09:29 EDT","volume":3113,"amount":8340.8934411,"timestamp":1777296596076,"change":0.04,"changeRate":0.015267,"amplitude":0.114504},"postHourTrading":{"tag":"盘后","latestPrice":2.57,"preClose":2.57,"latestTime":"16:10 EDT","volume":15,"amount":38.55,"timestamp":1777320604874,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.156786,"impliedVol":0.3488,"impliedVolPercentile":0.2151},"requestUrl":"/m/hq/s/NAUT","defaultTab":"news","newsList":[{"id":"2617591395","title":"Nautilus Biotechnology, Inc.盘中异动 大幅上涨5.39%报2.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617591395","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617591395?lang=zh_cn&edition=full","pubTime":"2026-03-04 23:05","pubTimestamp":1772636732,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日23时05分，Nautilus Biotechnology, Inc.股票出现异动，股价大幅拉升5.39%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Can Fite Biopharma Ltd、Scisparc Ltd.、Dianthus Therapeutics, Inc.涨幅较大，Can Fite Biopharma Ltd、Klotho Neurosciences, Inc.、Edesa Biotech, Inc.较为活跃，换手率分别为2160.20%、52.94%、40.78%，振幅较大的相关个股有Klotho Neurosciences, Inc.、Can Fite Biopharma Ltd、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为51.24%、41.60%、39.80%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304230532a44bca35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304230532a44bca35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103139468","title":"Nautilus Biotechnology, Inc. 预计2026年运营支出将较2025年增长约15%至20%——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1103139468","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103139468?lang=zh_cn&edition=full","pubTime":"2026-02-26 19:27","pubTimestamp":1772105269,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会（SEC）的最新文件，生物技术公司Nautilus Biotechnology, Inc. 对其未来财务支出作出预测。公司预计，在2026财年，其运营支出将呈现显著上升趋势，同比2025年增幅大约在15%到20%之间。\n这一预测揭示了公司在推进其生物技术研发和商业拓展过程中可能面临的成本增长。运营费用的增加通常关联于研发投入的加大、人才团队的扩充以及市场拓展活动的加强，这也从侧面反映了公司对未来业务发展的积极规划与投入决心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156971400","title":"Nautilus Biotechnology Inc. 2026年早期访问项目预计不会带来实质性收入","url":"https://stock-news.laohu8.com/highlight/detail?id=1156971400","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156971400?lang=zh_cn&edition=full","pubTime":"2026-02-26 19:22","pubTimestamp":1772104971,"startTime":"0","endTime":"0","summary":"Nautilus Biotechnology Inc. 近日表示，公司在2026年之前预计不会从早期访问项目合作中获得实质性收入。这一声明揭示了公司商业化进程的阶段性特征，同时也反映出生物科技企业在产品市场化初期普遍面临的营收挑战。作为专注于蛋白质组学技术开发的创新企业，Nautilus目前仍处于技术验证和平台优化阶段。随着蛋白质组学技术在药物研发、疾病诊断等领域的应用价值日益凸显，Nautilus所专注的技术方向具备广阔的市场前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAUT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612494425","title":"Nautilus Biotechnology, Inc.盘中异动 股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612494425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612494425?lang=zh_cn&edition=full","pubTime":"2026-02-18 22:57","pubTimestamp":1771426665,"startTime":"0","endTime":"0","summary":"北京时间2026年02月18日22时57分，Nautilus Biotechnology, Inc.股票出现波动，股价大幅拉升5.39%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218225745a4b09ef4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218225745a4b09ef4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609926103","title":"Nautilus Biotechnology, Inc.盘中异动 股价大跌5.14%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609926103","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609926103?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:58","pubTimestamp":1770217094,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日22时58分，Nautilus Biotechnology, Inc.股票出现异动，股价大幅跳水5.14%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Liminatus Pharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Gri Bio, Inc.、Evogene Ltd.较为活跃，换手率分别为375.40%、195.61%、106.95%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Liminatus Pharma, Inc.，振幅分别为61.25%、33.87%、31.77%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204225814a47c64d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204225814a47c64d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585345129","title":"Nautilus Biotechnology, Inc.盘中异动 股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585345129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585345129?lang=zh_cn&edition=full","pubTime":"2025-11-22 00:28","pubTimestamp":1763742539,"startTime":"0","endTime":"0","summary":"北京时间2025年11月22日00时28分，Nautilus Biotechnology, Inc.股票出现波动，股价急速拉升5.44%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122002900a7096c48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122002900a7096c48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585190598","title":"Nautilus Biotechnology, Inc.盘中异动 股价大涨5.39%报2.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585190598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585190598?lang=zh_cn&edition=full","pubTime":"2025-11-20 22:55","pubTimestamp":1763650513,"startTime":"0","endTime":"0","summary":"北京时间2025年11月20日22时55分，Nautilus Biotechnology, Inc.股票出现异动，股价大幅上涨5.39%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为1.45%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Annexon, Inc.、Design Therapeutics, Inc.涨幅较大，Psyence Biomedical Ltd.、Clearmind Medicine Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为959.86%、39.19%、14.94%，振幅较大的相关个股有Biorestorative Therapies, Inc.、Seres Therapeutics, Inc.、康乃德生物，振幅分别为21.68%、20.85%、20.32%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120225513a4af849e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120225513a4af849e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584991078","title":"Nautilus Biotechnology, Inc.盘中异动 股价大涨5.00%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584991078","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584991078?lang=zh_cn&edition=full","pubTime":"2025-11-19 00:57","pubTimestamp":1763485076,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日00时57分，Nautilus Biotechnology, Inc.股票出现异动，股价急速拉升5.00%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Olema Pharmaceuticals, Inc.、Yd Bio Ltd C/Wts 28/08/2030、Iterum Therapeutics Plc涨幅较大，Can Fite Biopharma Ltd、Clearmind Medicine Inc.、Galmed Pharmaceuticals Ltd.较为活跃，换手率分别为1924.34%、1106.26%、373.84%，振幅较大的相关个股有Olema Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Can Fite Biopharma Ltd，振幅分别为106.34%、60.49%、59.39%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119005757950c9b05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119005757950c9b05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580409789","title":"Nautilus Biotechnology, Inc.盘中异动 临近午盘急速拉升5.26%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580409789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580409789?lang=zh_cn&edition=full","pubTime":"2025-11-04 00:30","pubTimestamp":1762187436,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日00时30分，Nautilus Biotechnology, Inc.股票出现异动，股价急速上涨5.26%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为1.63%。其相关个股中，Terns Pharmaceuticals, Inc.、Surrozen Inc C/Wts 01/08/2031 、Phio Pharmaceuticals Corp.涨幅较大，Phio Pharmaceuticals Corp.、Tharimmune, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为2354.30%、555.65%、365.63%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Tharimmune, Inc.、Phio Pharmaceuticals Corp.，振幅分别为142.59%、129.83%、66.82%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110400303697516108&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110400303697516108&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198960781","title":"诺特勒斯2025财年Q3业绩会总结及问答精华：Tau蛋白检测与市场热情推动增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1198960781","media":"业绩会速递","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198960781?lang=zh_cn&edition=full","pubTime":"2025-10-29 06:11","pubTimestamp":1761689478,"startTime":"0","endTime":"0","summary":"公司计划在2026年上半年推出Tau蛋白检测的早期访问计划，并在2026年底进行全面商业化。研发费用为960万美元，同比下降22%。净亏损为1360万美元，较2024年同期的1640万美元有所减少。公司现金、现金等价物和投资总额为1.685亿美元，预计现金流可支持运营至2027年。渠道建设正在进行中，预计2026年第一季度将进行首次商业招聘。诺特勒斯在2025年第三季度取得了显著进展，特别是在其蛋白质组学平台的外部验证方面。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159354358","title":"Nautilus Biotechnolgy, Inc. - 预计将在2026年上半年推出包含Tau蛋白变体的早期访问程序","url":"https://stock-news.laohu8.com/highlight/detail?id=1159354358","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159354358?lang=zh_cn&edition=full","pubTime":"2025-10-28 18:11","pubTimestamp":1761646311,"startTime":"0","endTime":"0","summary":"Nautilus Biotechnolgy, Inc. - 预计将在2026年上半年推出包含Tau蛋白变体的早期访问程序","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2578939376","title":"Nautilus Biotechnology, Inc.盘中异动 早盘股价大涨5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578939376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578939376?lang=zh_cn&edition=full","pubTime":"2025-10-27 22:16","pubTimestamp":1761574610,"startTime":"0","endTime":"0","summary":"北京时间2025年10月27日22时16分，Nautilus Biotechnology, Inc.股票出现异动，股价急速拉升5.74%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、戴纳基、Avidity Biosciences, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Aditxt, Inc.、Cellectar Biosciences, Inc.较为活跃，换手率分别为147.75%、133.45%、123.48%，振幅较大的相关个股有Ethzilla Corporation C/Wts 06/11/2025、Fate Therapeutics, Inc.、冠科美博，振幅分别为31.00%、23.63%、19.22%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一种用于量化和解锁人类蛋白质组复杂性的平台技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102722165094e0191e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102722165094e0191e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518277937","title":"Nautilus Biotechnology, Inc.盘中异动 快速跳水5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518277937","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518277937?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:12","pubTimestamp":1741623169,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时12分，Nautilus Biotechnology, Inc.股票出现异动，股价快速下挫5.33%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3682.99%、3106.33%、934.80%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Aeon Biopharma, Inc.、Scisparc Ltd.，振幅分别为88.14%、78.32%、49.87%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031100124996405771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031100124996405771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517458105","title":"Nautilus Biotechnology, Inc.2024财年实现净利润-70.78百万美元，同比减少11.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517458105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517458105?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363244,"startTime":"0","endTime":"0","summary":"3月8日，Nautilus Biotechnology, Inc.公布财报，公告显示公司2024财年净利润为-70.78百万美元，同比减少11.15%；其中营业收入为0.00美元，每股基本收益为-0.56美元。机构评级：截至2025年3月8日，当前有3家机构对Nautilus Biotechnology, Inc.目标价做出预测，其中目标均价为2.17美元，其中最低目标价为1.00美元，最高目标价为3.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000140a2647ece&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000140a2647ece&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517928381","title":"Nautilus Biotechnology, Inc.盘中异动 下午盘快速下跌5.00%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517928381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517928381?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:36","pubTimestamp":1741289806,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时36分，Nautilus Biotechnology, Inc.股票出现波动，股价快速跳水5.00%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033646989ee927&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033646989ee927&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514320017","title":"Nautilus Biotechnology, Inc.盘中异动 股价大涨6.41%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514320017?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:35","pubTimestamp":1740753312,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时35分，Nautilus Biotechnology, Inc.股票出现异动，股价大幅上涨6.41%。截至发稿，该股报1.25美元/股，成交量6775股，换手率0.01%，振幅0.00%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223512a258022b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223512a258022b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT","BK4121","BK4007","VRPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514386241","title":"Nautilus Biotechnology, Inc.盘中异动 股价大跌11.89%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386241?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:30","pubTimestamp":1740666624,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时30分，Nautilus Biotechnology, Inc.股票出现波动，股价快速下挫11.89%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722302498950fb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722302498950fb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADAG","BK4139","NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110538525","title":"鹦鹉螺生物科技第四季度GAAP每股收益$(0.14)优于预期$(0.16)","url":"https://stock-news.laohu8.com/highlight/detail?id=1110538525","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110538525?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:38","pubTimestamp":1740659934,"startTime":"0","endTime":"0","summary":"鹦鹉螺生物科技报告的季度每股亏损为$，比分析师普遍预期的$好12.5％，与去年同期持平。以上内容来自Benzinga Earnings专栏，原文如下：Nautilus Biotechnology  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 12.5 percent. This is unchanged from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"鹦鹉螺生物科技第四季度GAAP每股收益$(0.14)优于预期$(0.16)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511457979","title":"Nautilus Biotechnology, Inc.盘中异动 股价大涨6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511457979","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511457979?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:23","pubTimestamp":1739474607,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日03时23分，Nautilus Biotechnology, Inc.股票出现波动，股价大幅拉升6.25%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为1.17%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Dominari Holdings Inc.涨幅较大，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3183.07%、1982.56%、1233.56%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为733.31%、95.15%、92.30%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214032327abcdeaee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214032327abcdeaee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","NAUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510333685","title":"Nautilus Biotechnology, Inc.盘中异动 急速下跌5.29%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510333685","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510333685?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:44","pubTimestamp":1739288678,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时44分，Nautilus Biotechnology, Inc.股票出现波动，股价急速下挫5.29%。Nautilus Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为1.83%。其相关个股中，Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2717.08%、1094.41%、376.48%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为58.60%、57.43%、39.00%。Nautilus Biotechnology, Inc.公司简介：Nautilus Biotechnology Inc是一家处于发展阶段的生命科学公司，创建了一个平台技术，用于量化和解锁人类蛋白质组的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211234438abcb165a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211234438abcb165a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAUT","OCEA","BK4121","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nautilus.bio","stockEarnings":[{"period":"1week","weight":-0.1353},{"period":"1month","weight":-0.3299},{"period":"3month","weight":0.2657},{"period":"6month","weight":1.1475},{"period":"1year","weight":2.6746},{"period":"ytd","weight":0.3436}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.087},{"period":"3month","weight":0.0359},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nautilus Biotechnology, Inc.于2020年3月27日在开曼群岛注册成立，是一家豁免公司，并于2021年6月8日在特拉华州重新注册成立。他们是一家处于发展阶段的生命科学公司，致力于创建用于量化和解锁人类蛋白质组复杂性的平台技术。他们的使命是通过使蛋白质组的访问民主化并实现人类健康和医学的根本进步来改变蛋白质组学领域。他们认为，现有技术的渐进式进步是不够的，需要进行大胆的科学飞跃才能彻底改造蛋白质组学并彻底改变精准医学。他们的愿景是整合他们在计算机科学、工程和生物化学方面的突破性创新，以开发和商业化具有极高灵敏度和规模的蛋白质组学分析技术。为了实现这一目标，他们建立了一个单分子仪器的原型，即他们的蛋白质组学分析系统，该系统将得到进一步开发，以提供他们认为建立新的黄金标准所必需的速度、简单性、准确性和多功能性场地。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.028311},{"month":2,"riseRate":0.666667,"avgChangeRate":0.077747},{"month":3,"riseRate":0.666667,"avgChangeRate":0.104644},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.140619},{"month":5,"riseRate":0.6,"avgChangeRate":-0.003176},{"month":6,"riseRate":0.2,"avgChangeRate":-0.022509},{"month":7,"riseRate":0.6,"avgChangeRate":-0.017062},{"month":8,"riseRate":0.2,"avgChangeRate":-0.079652},{"month":9,"riseRate":0.5,"avgChangeRate":0.010868},{"month":10,"riseRate":0.333333,"avgChangeRate":0.046365},{"month":11,"riseRate":0.5,"avgChangeRate":0.048822},{"month":12,"riseRate":0.5,"avgChangeRate":-0.033204}],"exchange":"NASDAQ","name":"Nautilus Biotechnolgy, Inc.","nameEN":"Nautilus Biotechnolgy, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nautilus Biotechnolgy, Inc.(NAUT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nautilus Biotechnolgy, Inc.(NAUT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nautilus Biotechnolgy, Inc.,NAUT,Nautilus Biotechnolgy, Inc.股票,Nautilus Biotechnolgy, Inc.股票老虎,Nautilus Biotechnolgy, Inc.股票老虎国际,Nautilus Biotechnolgy, Inc.行情,Nautilus Biotechnolgy, Inc.股票行情,Nautilus Biotechnolgy, Inc.股价,Nautilus Biotechnolgy, Inc.股市,Nautilus Biotechnolgy, Inc.股票价格,Nautilus Biotechnolgy, Inc.股票交易,Nautilus Biotechnolgy, Inc.股票购买,Nautilus Biotechnolgy, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nautilus Biotechnolgy, Inc.(NAUT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nautilus Biotechnolgy, Inc.(NAUT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}